Moors & Cabot, Inc.
- SEC CIK
- 0001607239
- Latest filing
- Aug 10, 2026
DGX holding history
Quest Diagnostics Inc in every 13F filed by Moors & Cabot, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DGX overviewAll 13F holders of DGXFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,984
- Value
- $420.5K
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,984 | $420.5K | <0.1% | −132−6.2% | Reduced | Holders |
| Q1 2026 | 2,116 | $414.8K | <0.1% | −548−20.6% | Reduced | Holders |
| Q4 2025 | 2,664 | $462.2K | <0.1% | +439+19.7% | Added | Holders |
| Q3 2025 | 2,225 | $424.0K | <0.1% | +2,225 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −18,045−100.0% | Sold out | Holders |
| Q4 2023 | 18,045 | $2.49M | 0.2% | +260+1.5% | Added | Holders |
| Q3 2023 | 17,785 | $2.17M | 0.1% | −429−2.4% | Reduced | Holders |
| Q2 2023 | 18,214 | $2.56M | 0.2% | −1,540−7.8% | Reduced | Holders |
| Q1 2023 | 19,754 | $2.79M | 0.2% | −377−1.9% | Reduced | Holders |
| Q4 2022 | 20,131 | $3.15M | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2022 | 20,131 | $2.47M | 0.2% | +29+0.1% | Added | Holders |
| Q2 2022 | 20,102 | $2.67M | 0.2% | −152−0.8% | Reduced | Holders |
| Q1 2022 | 20,254 | $2.77M | 0.2% | −109−0.5% | Reduced | Holders |
| Q4 2021 | 20,363 | $3.52M | 0.2% | +124+0.6% | Added | Holders |
| Q3 2021 | 20,239 | $2.94M | 0.2% | +5,522+37.5% | Added | Holders |
| Q2 2021 | 14,717 | $1.94M | 0.1% | +14,717 | New | Holders |